Background. Current, nationally representative data on rotavirus disease burden and rotavirus strains in India are needed to understand the potential health benefits of rotavirus vaccination.
a million deaths annually among children aged !5 years, with the majority of these deaths occurring in developing countries [1] . India alone is estimated to account for approximately one-quarter of the global deaths from rotavirus. Safe and effective rotavirus vaccines have recently been introduced in several industrialized and middle-income countries [2] and may soon be recommended for use in developing countries, once the results of ongoing clinical efficacy trials are available. Nationally representative data on rotavirus disease burden and strains are needed by decision makers to understand the potential health benefits of introducing these vaccines, especially in countries with large and diverse populations, such as India.
Although several studies on rotavirus disease and strains have been performed in India, collation of data is frequently not possible, because of differences in study design, the populations examined, and the rotavirus detection assays used [3] . Furthermore, whereas great strain diversity has been observed in studies in specific locations [3] , limited contemporary data on strain prevalences in different geographic regions of the country are available. Therefore, the Indian Rotavirus Strain Surveillance Network was established in December 2005 to generate timely and geographically representative information on the clinical, epidemiological, and virological features of severe rotavirus disease in Indian children, with use of standardized protocols for enrollment and diagnostic evaluation. Here, we report the results of the first 2 years of surveillance through this network.
METHODS

Study sites.
The study was conducted with patient recruitment at 10 representative hospitals in 7 cities and with testing at 4 laboratories in different parts of India (Figure 1 ), by using a modification of the World Health Organization generic protocol [4] . The study was coordinated for statistical analysis by the National Institute of Epidemiology (Chennai, India). The study was administratively and technically coordinated by the Indian Council for Medical Research (New Delhi, India) and by the US Centers for Disease Control and Prevention (Atlanta, GA).
Enrollment criteria. All children aged р59 months who presented to a study hospital with acute gastroenteritis and required hospitalization with rehydration for at least 6 h were enrolled after informed and written consent was obtained from the parent or guardian. Children aged у60 months and those who did not require supervised oral or intravenous rehydration were excluded.
Clinical assessment. Detailed clinical data on the onset and duration of diarrhea and on vomiting, fever, and dehydration were collected. Information was recorded on the duration of diarrhea, maximum number of stools passed per day, duration and peak frequency of vomiting, degree of fever, presence and severity of dehydration, and treatment. The severity of diarrhea was assessed using the Vesikari scoring system [5] . An episode was considered to be mild for Vesikari scores 0-5, moderate for scores 6-10, severe for scores 11-15, and very severe for scores 16-20. Sample collection. One stool specimen was collected from each child enrolled in the study. All stool samples collected in the hospitals were transported within 2 h to the testing laboratory or to storage at 4ЊC until testing. Samples stored at 4ЊC after collection were transported in boxes with ice packs at 15-day intervals to the testing laboratory. All samples were tested for rotavirus on the day that they were received at the laboratory, and aliquots of samples were stored at Ϫ70ЊC for additional studies.
Laboratory procedures. The standardized laboratory protocol developed for this study was to screen all samples by an immunoassay, to screen for antigen, and to perform genotyping for VP7 and VP4 by reverse-transcription polymerase chain reaction (RT-PCR); to ensure quality control, all laboratories used the same protocol and reagents. The samples were tested for the presence of rotavirus VP6 antigen with use of an enzyme immunoassay (EIA; Rota IDEIA; Dako). For characterization by PCR, viral RNA was extracted from 30% EIA-positive fecal suspensions with use of Trizol reagent (Invitrogen Life Technologies). Complementary DNA synthesized using random primers (Pd(N)6 hexamers; Pharmacia Biotech) and 400 units of Moloney murine leukemia virus reverse transcriptase (Invitrogen Life Technologies) were used as template for VP7 and VP4 (G and P) typing in PCRs using published oligonucleotide primers and protocols. The primers could amplify VP7 genotypes G1, G2, G3, G4, G8, G9, G10, and G12 and VP4 genotypes P [4] , P [6] , P [8] , P [9] , P [10] , and P [11] [6, 7] . The initial genotyping protocol did not include a primer for G12, but because G12 strains were being seen in other studies [6, [8] [9] [10] [11] , the primer was included prospectively in 2007, and all previously untyped samples were also tested. Samples that were positive by EIA but negative by genotyping were tested using PCR for the VP6 gene, to confirm rotavirus positivity. Strains that could not be typed by standard techniques were further evaluated by sequencing. The protocol included quality assurance by blinded evaluations of screening and genotyping of samples exchanged between laboratories, which was coordinated by the National Institute of Epidemiology and the Christian Medical College. Statistical analysis. All sites submitted summary data on all diarrhea-related hospital admissions and rotavirus testing monthly to the coordinating center. Case report forms and genotyping results were submitted quarterly. The forms were scrutinized for completeness, and the data were entered into Excel 2003 (Microsoft) and were cleaned. Analysis was performed using Systat, version 8 (Systat Software). Tests of proportion were applied. A P value !.05 was considered to be statisticaly significant.
Ethics. The study was approved by the institutional review boards (ethics committees) of the National Institute of Virology, Pune, India; the National Institute of Cholera and Enteric Diseases, Kolkata, India; Lokmanya Tilak Municipal General Hospital, Mumbai, India; Christian Medical College, Vellore, India; and the Centers for Disease Control and Prevention.
RESULTS
Hospitalization for diarrhea and rotavirus infection.
During the 2 years of surveillance, a total of 4243 eligible children were admitted with diarrhea at all 10 hospitals (Table 1) . Stool samples were collected from 3580 (84.4%) of the children. Rotavirus was detected in samples from 1405 children, accounting for 39.2% of all patients admitted for diarrhea for whom rotavirus testing was performed. The detection rate of rotavirus ranged from 35% in Mumbai to 53% in Trichy (Table 1) .
Rotavirus infections were seen throughout the year at all surveillance sites. However, the proportion of rotavirus-positive cases was higher for the months of December through February than for the rest of the year, during both years of study (P ! ), although these differences were not marked at most sites. .001 The northernmost study site at Delhi, which has the most temperate climate, had the most distinct winter seasonal peaks, with 170% of diarrhea cases being identified as caused by rotavirus during this period (Figure 2 ). In contrast, the least difference in seasonal patterns was observed in the 2 centers in southern India at Vellore and Trichy, which have tropical climates.
We examined the demographic characteristics of children hospitalized with diarrhea ( The mean age of children hospitalized with diarrhea was 14.1 months. The mean age ‫ע(‬ standard deviation) of rotavirus-infected children was months, which was sig-12.9 ‫ע‬ 9.0 nificantly lower ( ) than that of rotavirus-uninfected chil-P ! .01 dren ( months). The highest percentages of cases 15.0 ‫ע‬ 12.5 positive for rotavirus occurred in the age groups 6-11 months and 12-23 months at all sites (36.5% and 38.9%, respectively) ( Figure 3) . Of all children with rotavirus diarrhea, 13.3% were aged !6 months.
In general, children with rotavirus diarrhea had more severe disease than did those with rotavirus-negative disease (mean severity scores, 11.7 vs. 11.2; ), although the mean du-P ! .01 
ration of hospitalization was similar (3.4 days for both groups).
Children with rotavirus infection had more episodes and longer durations of vomiting than did uninfected children. Children hospitalized with rotavirus gastroenteritis had significantly less mild and moderate disease and significantly more severe disease than did rotavirus-negative children (Table 2) . Genotyping. Strain characterization was performed for all stool samples that tested positive by EIA. Of the 1405 samples that were rotavirus positive by EIA, genotyping was performed for 1375 strains (97.9%); of those strains, 1177 (85.6%) could be G typed, and 1166 (84.8%) could be P typed (Table 3) . Both G and P types were determined for 946 (68.8%) of the 1375 genotyped strains. The most prevalent G and P type combinations were G2P [4] [4] , G1P [6] , G2P [6] , G2P [8] , G9P [4] , and G9P [6] , were seen at all surveillance sites repeatedly ( Table  4 ). Strains that were identified only once or twice were G3P [8] , G4P [4] , G10P [6] , and G2P [10] , all from Pune, and G10P [11] from Vellore. Mixed infections (Table 5) were common, with ∼8% of samples from Vellore, Pune, and Mumbai having 11 rotavirus strain, but the percentage of mixed infections was highest in Imphal (38.5%).
G12 strains were seen in combination with P [4] , P [6] , and P [8] and comprised 90 (6.5%) of 1375 G-typed strains. The highest numbers of G12 strains were identified in Mumbai and Delhi ( Figure 4) ; from December 2006 through February 2007, G12 strains comprised 15% of the strains in Mumbai and 20% in Delhi. During the most recent surveillance period, from September through November 2007, G12 strains were increasingly common, comprising 50% of the rotavirus strains identified in Mumbai and 37% in Trichy. However, in Imphal and Pune, G12 strains were less common during the period of surveillance. G9 strains were the second most common strains in Vellore and Trichy, the southern centers, whereas they were third most common in Delhi, indicating significant geographic differences in strain circulation in India.
DISCUSSION
In this study, with a standardized, quality-controlled approach at several sites across India, rotavirus was detected in 39% of [3] ; these findings were similar to those in an earlier review [12] . These studies used several different methods for detection of rotavirus, such as latex agglutination, enzyme-linked immunosorbent assay, electron microscopy, and polyacrylamide gel electrophoresis. The establishment of a rigorous surveillance network and the use of a single standard protocol for case definition and laboratory evaluation have shown that the burden of rotavirus disease among hospitalized children is much greater than that previously estimated. In addition, patterns of diarrheal etiology are changing across the world, with viral pathogens becoming increasingly more common [13] [14] [15] [16] , possibly because less severe cases of diarrhea due to other etiologies may be effectively treated at home with oral rehydration. The study also documents the early incidence of rotavirus disease in India. The percentage of children with dehydrating gastroenteritis who were aged !3 months was 3.5%, and the percentage aged !6 months was 13.3%; these findings have clear implications for future immunization programs, because immunity will need to be induced early in children in developing countries, to afford protection from rotavirus disease, which is a possibility if immunity is induced by the first dose of a vaccine given exactly according to the immunization schedule.
Clear seasonality in rotavirus disease in tropical climates has not been convincingly demonstrated, although an earlier study from central India showed that rotavirus disease was more common during cooler months, with seasonal peaks matching the lowest temperatures [17] . In this study, a distinct winter peak was seen in the months of December and January during the 2 years of surveillance at the site in Delhi, which has the most marked temperature changes (Figure 2) . At all other sites, although the rates of rotavirus positivity did not peak during these months, a high proportion of positivity was seen during the months of December through February. It is interesting to note that this trend was not seen in the 2 centers in southern India, which has the least annual variation in temperature.
The worldwide emergence of the G12 strain in 2005 and its increasing incidence during the past 2 years parallels the emergence and subsequent spread of G9 strains that occurred approximately a decade ago. In the mid-1990s, G9P [6] and G9P [8] strains were reported in India, Japan, the United Kingdom, and the United States. Subsequently, G9P [8] spread globally, and it currently accounts for 4.1% of all rotavirus infections globally [18] . G12 strains have been found in association with multiple VP4 types, namely P [4] , P [6] , P [8] , and P [9] , suggesting reassortment among commonly circulating strains [10, 19, 20] . The increased reporting of infection with G12 strains may be associated with reassortment, resulting in generation of a strain that is better adapted to replication in humans, similar to the events that preceded the spread of G9 strains in the past decade. The emergence of G12 strains highlights the need for a surveillance system to respond rapidly to changes in circulating virus and to ensure that vaccines remain effective against emerging strains. For the 2 vaccines that are currently licensed for use in many countries [2] , 22.1% of the strains identified in this study would be covered by Rotarix (GSK Biologicals) and 47.9% by RotaTeq (Merck), if only homotypic immunity is induced by vaccination, although reports from Europe indicate cross-protection across genotypes with use of Rotarix [21] .
The relative low levels of complete identification of strains by genotyping, despite the use of specific priming and sequencing of first-round products, could be partially explained by the fact that samples were stored at 4ЊC at site hospitals before transportation to the testing laboratories, but there appeared to be no difference in the proportion of incompletely or untyped samples from centers where testing was onsite, compared with samples transported from a remote location. This low level of identification by genotyping has been reported previously in India [22] and may require more-rigorous sample collection and testing. In addition to the challenges posed by the emergence of new strains in the population under surveillance, there were high levels of circulation of unusual recombinant strains, such as G1P [4] , G1P [6] , G2P [6] , G2P [8] , G9P [4] , and G9P [6] , in different parts of the country. In previous reports from India, G1P [4] strains have been reported with varying frequency from different sites [22, 23] . A study in Vellore found more G1P [4] strains in diarrhea samples from nonhospitalized children than in those from hospitalized children, indicating a possible relationship with severity [24] . Both the number of reassortant strains and the high proportion of mixed infections are an indication of the variety of sources from which children likely acquire infections.
In summary, this study highlights the high prevalence of rotavirus gastroenteritis in India, the higher severity of rotavirus disease than that of other diarrheal diseases, and the circulation of a diverse range of rotavirus strains, including several uncommon and emerging strains. The complexity of rotavirus epidemiology poses significant challenges for a surveillance network [25, 26] . The 2 years of surveillance reported in this article have generated geographically representative, robust data to inform public health policy in India. With the prospect of rotavirus vaccine introduction in the near future, the importance of rigorous surveillance to monitor disease and strains before and after vaccine introduction cannot be overemphasized.
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